Skip to content
LexBuild

Issuance of Final Guidance Publication

---
identifier: "/us/fr/2014-22275"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Issuance of Final Guidance Publication"
title_number: 0
title_name: "Federal Register"
section_number: "2014-22275"
section_name: "Issuance of Final Guidance Publication"
positive_law: false
currency: "2014-09-18"
last_updated: "2014-09-18"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2014-22275"
document_type: "notice"
publication_date: "2014-09-18"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "79 FR 56078"
fr_volume: 79
docket_ids:
  - "CDC-2013-0007"
  - "Docket Number NIOSH-233"
fr_action: "Notice of issuance of final guidance publication."
---

#  Issuance of Final Guidance Publication

**AGENCY:**

National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

**ACTION:**

Notice of issuance of final guidance publication.

**SUMMARY:**

The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) announces the publication of the following document entitled “NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014.”

**ADDRESSES:**

This document is available at the following link: *http://www.cdc.gov/niosh/docs/2014-138/pdfs/2014-138.pdf.*

**FOR FURTHER INFORMATION CONTACT:**

Barbara MacKenzie, NIOSH, 1090 Tusculum Avenue, MS-C26, Cincinnati, Ohio 45226, telephone (513) 533-8132, email *[email protected].*

Dated: September 11, 2014.

John Howard,

Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.